We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

This study has suspended participant recruitment.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00804154
First Posted: December 8, 2008
Last Update Posted: October 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Sorrento Therapeutics, Inc.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Dental and Craniofacial Research (NIDCR) )
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 30, 2020
  Estimated Primary Completion Date: June 30, 2020 (Final data collection date for primary outcome measure)